GILD

#83
Gilead Sciences, Inc. - Common Stock
148.8 6 USD
+0.01%
Market Price
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
148.85
148.86
년간 변동
108.46
157.27
일일 변동
+0.52%
월간 변동
+10.75%
6달 변화
+0.72%
년간 변동율
+32.19%
이전 종가
148.0 9
Open
148.8 5
저가
148.8 5
고가
148.8 6
양
280
전체 차트 열기

Financials

개요 성명 통계 배당금 Documents

2026

Current report, Q3 FY2026
GILEAD SCIENCES, INC. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
GILEAD SCIENCES, INC. quarterly report, Q2 FY2026
10-Q
Institutional holdings, Q2 FY2026
GILEAD SCIENCES, INC. institutional holdings, Q2 FY2026
13F-HR
INFORMATION TABLE, Q2 FY2026
GILEAD SCIENCES, INC. INFORMATION TABLE, Q2 FY2026
INFORMATION TABLE
Current report, Q2 FY2026
GILEAD SCIENCES, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
GILEAD SCIENCES, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
GILEAD SCIENCES, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
GILEAD SCIENCES, INC. current report, Q2 FY2026
8-K
Institutional holdings, Q1 FY2026
GILEAD SCIENCES, INC. institutional holdings, Q1 FY2026
13F-HR
Quarterly report, Q1 FY2026
GILEAD SCIENCES, INC. quarterly report, Q1 FY2026
10-Q

GILEAD SCIENCES, INC. current report, Q4 FY2025

Full document

Business Context and Reporting Period

Company: Gilead Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: October 30, 2025
Reporting Period: Quarter ended September 30, 2025

This filing announces the financial results for the third quarter of 2025. The report includes both GAAP and non-GAAP financial information, with a full reconciliation provided in the attached press release (Exhibit 99.1).

Key Financial Metrics

The filing text serves as a cover document and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being contained within the press release filed as Exhibit 99.1.

  • Revenue: Not provided in filing text.
  • Profit: Not provided in filing text.
  • Cash Flow: Not provided in filing text.
  • Margins: Not provided in filing text.
  • Debt and Liquidity: Not provided in filing text.

Material Changes

The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to Exhibit 99.1 for comparative analysis.

Guidance, Outlook, and Management Commentary

Management Commentary: Management states that non-GAAP information is useful for investors when considered alongside GAAP statements, as it is used internally for operating, budgeting, and financial planning. The filing notes that non-GAAP measures may be defined differently by other companies in the industry.

Guidance and Risks: The filing text does not contain specific forward-looking guidance, risk factors, contingencies, or unusual items. These details are expected to be in the attached press release.

Investor Verification Checklist

  • Review Exhibit 99.1 (Press Release) for specific Q3 2025 revenue and net income figures.
  • Examine the reconciliation tables (pages 9-11 of Exhibit 99.1) to understand adjustments between GAAP and non-GAAP results.
  • Verify year-over-year and quarter-over-quarter growth rates in the attached press release.
  • Check for any updated full-year 2025 guidance or strategic updates in the press release.

뉴스